Zenitar's structural biology platform efficiently utilizes X-ray crystallography and cryo-EM to analyze protein-drug complex structures for pipeline targets. When deeply integrated with the AI-driven drug design platform, it drives innovation in molecular scaffolds and enhances affinity and selectivity.